Only 1 Suit Left In Eliquis MDL As 20 More Cases Get Cut
Pfizer Inc. and Bristol-Myers Squibb Co. have largely beat multidistrict litigation accusing them of not properly warning about the risks tied to the blood thinner Eliquis after a New York federal...To view the full article, register now.
Already a subscriber? Click here to view full article